National and Kapodistrian University of Athens
Διασπορά των γονιδίων αντοχής στις μακρολίδες και τις λινκοσαμίδες σε στελέχη σταφυλοκόκκων που απομονώνονται σε ελληνικά νοσοκομεία
Abstract
dc:descriptionIn Greece, as in many other countries, methicillin-resistant staphylococcal strains (S. aureus, coagulase-negative staphylococci) are the major cause of nosocomial infections. The treatment of these infections is difficult, as many of the methicillin-resistant staphylococci exhibit cross-resistance to a broad spectrum of antimicrobial agents. Clones of these multiresistant staphylococcal strains can easily predominate in the nosocomial environment and spread in different hospital care units. Macrolides (such as erythromycine) and lincosamides (such as clindamycine), which are chemically distinct antimicrobial agents but share a similar mode of action, are widely used in the treatment of staphylococcal infections. However, resistance to macrolides and lincosamides is common among staphylococci and mostly among those that exhibit resistance to methicillin. Three main mechanisms of resistance to macrolides and lincosamides have been described in staphylococci: target modification (ribosomal modification by 23S rRNA methylase mediated by ermA, ermB and ermC genes), the presence of multicomponent macrolide-efflux pumps (encoded by msrA, msrB genes) and the enzymatic inactivation of the macrolides by enzymes such as esterases EreA and EreB (encoded by ereA and ereB genes, respectively) and phosphorotransferases type II (encoded by mphC gene) and enzymatic inactivation of lincosamides by enzymes encoded by lnuA/Α΄. The expression of the first mechanism of resistance can be constitutive (resistance to all MLSB antibiotics) or inducible (resistance to 14, 15-macrolides but susceptibility to 16-macrolides, lincosamides and streptogramins B which is phenotypically presented by a flattening of the zone of inhibition, the D shaped zone, around the clindamycine disc when a disc of erythromycine is placed near a disc of clindamycine). The occurrence of efflux pump system causes resistance to macrolides and streptogramins B (MSB resistance). The aim of the present study was to determine the incidence of macrolides and lincosamides resistance among methicillin-resistant and methicillin-susceptible staphylococcal isolates in Greek hospitals by determining the minimum inhibitory concentrations of these antibiotics. It was also attempted to determine the phenotypes of resistance and the molecular mechanisms of resistance as well the genetic relatedness of isolates in order to mode of spread among multi-resistant staphylococcal strains in Greek hospitals. The material of the study was consisted of 400 staphylococcal strains (278 S. aureus and 122 CNS) isolated from patients with clinical infections in 6 Greek hospitals (3 were located in Athens, 2 were located in Thessaloniki and the General Hospital of Korinthos) during 2001-2004. Antimicrobial susceptibility was performed by the agar microdilution method. Among these isolates, 207 (51,8%) were resistant to oxacillin and characterized as methicillin-resistant, 259 isolates (64,8%) were resistant to erythromycin and 162 (40,5%) to clindamycin. Furthermore, 5 isolates (1,3%) presented intermediate susceptibility to erythromycin. Intermediate susceptibility to clindamycine was not detected in any isolate. The phenotypes of resistance were detected by the double-disk diffusion method on agar plate. The MLSB constitutive phenotype was detected in 39,8% of the isolates (159 isolates: 121 S. aureus and 38 CNS), the MLSB inducible phenotype in 17,8% of the isolates (71 isolates: 47 S. aureus and 24 CNS), the MSB phenotype in 8,0% of the isolates (32 isolates:16 S. aureus and 16 CNS). The phenotype of resistance to lincosamides was found only in 3 S. aureus isolates (0,8%). Detection of the macrolide and lincosamide resistance genes by molecular assays was performed in 265 staphylococcal isolates that exhibited resistance or intermediate susceptibility to at least one of the antibiotics (erythromycin and clindamycin). The most prevalent gene of resistance was ermA (54,7% of isolates) followed by ermC (24,9% of isolates) and msrA/msrB (11,7% of isolates). Less frequently was detected lnuA/A΄ (1,1% of isolates). The ermB, ereA, ereB and mphC genes were not detected in any of the tested staphylococci. Eleven (4,2%) of the isolates were negative for all resistance genes. Among S. aureus isolates, ermA was the prevalent resistance gene (67,4%); it was more frequently in MRSA than in MSSA (74,5% in MRSA versus 45,7% in MSSA) and especially among those that exhibited the constitutive type of MLSB resistance. On the other hand, among CNS isolates the most prevalent gene was ermC (42,3%); it was detected mostly in MSCNS (48,3% in MSCNS versus 38,8% in MRCNS) and especially among those with the inducible type of MLSB resistance. The msrA/msrB genes were more prevalent in CNS (20,5%) than in S. aureus isolates (8,0%). The lnuA/A΄ gene was detected only in 3 S. aureus isolates (1,3%), but not in CNS isolates.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2006
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Κολλιού, Βασιλική
Subjects
dc:subject × 15- Σταφυλόκοκκος, Αντοχή στις μακρολίδες, λινκοσαμίδες
- Μακρολίδες, Γονίδια αντοχής
- Λινκοσαμίδες, Γονίδια αντοχής
- Σταφυλόκοκκος, Αντοχή στην ερυθρομυκίνη
- MLSB resistance in staphylococci
- Staphylococci, Macrolides resistance in
- Macrolides, Resistance genes
- Lincosamides, Resistance genes
- Staphylococcal Isolotes, MLSB resistance genes in
- Staphylococci, Erythromycine resistance in
- MRSA and MLSB resistance
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/16179